References
- Drummond MF, Pang E Transferability of economic evaluation results. In: Economic Evaluation in Healthcare: Merging Theory with Practice Drummond MF, McGuire A (Fds). Oxford, Oxford University Press, UK (2001).
- Pang F. Design, analysis and presentation of multinational economic studies: the need for guidance. PharmacoEconomics 20(2), 75–90 (2002).
- Drummond MF, Bloom BS, Carrin Get al Issues in the cross-national assessment of health technology. int/I Tech. Assessment Healthcare 8 (4), 671–682 (1992) .
- Menzin J, Oster G, Davies L etal. A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis. Intl J. Tech. Assessment Healthcare 12 (1), 52–61 (1996).
- Jonsson B, Weinstein WC. Economic evaluation alongside multinational clinical trials: study considerations for GUSTO IIb. Intl J. Tech. Assessment Healthcare 13 (1), 49–58 (1997).
- Willke RJ, Glick HA, Polsky D, Schulman K. Estimating country-specific cost-effectiveness from multinational clinical trials. Health Econ. 7(6), 481–493 (1998).
- Cook JR, Drummond M, Glick H, Heyse JE Assessing the appropriateness of combining economic data from multinational clinical trials. Statistics Med. (In Press).
- Hoch JS, Briggs AH, Willan AR Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ. 11(5), 415–430 (2002).
- Drummond MF, Barberi M. To what extent does the relative cost-effectiveness of drugs vary across Europe, and why? (Abstract) International Health Economics Association 4th World Congress, San Francisco, CA, USA, June 15–18 (2003).